These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21889247)

  • 21. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk of attention deficit/hyperactivity disorder in Aymara and Rapa-Nui school children: association with dopaminergic system polymorphisms].
    Paz Lagos L; Silva C; Rothhammer P; Carrasco X; Llop E; Aboitiz F; Rothhammer F
    Rev Med Chil; 2011 May; 139(5):600-5. PubMed ID: 22051710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD.
    Kim YS; Leventhal BL; Kim SJ; Kim BN; Cheon KA; Yoo HJ; Kim SJ; Badner J; Cook EH
    Neurosci Lett; 2005 Dec; 390(3):176-81. PubMed ID: 16165273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD.
    Muglia P; Jain U; Inkster B; Kennedy JL
    Neuropsychopharmacology; 2002 Oct; 27(4):655-62. PubMed ID: 12377402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD.
    Althaus M; Groen Y; Wijers AA; Minderaa RB; Kema IP; Dijck JD; Hoekstra PJ
    Biol Psychol; 2010 Sep; 85(1):19-32. PubMed ID: 20450954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD.
    Braet W; Johnson KA; Tobin CT; Acheson R; McDonnell C; Hawi Z; Barry E; Mulligan A; Gill M; Bellgrove MA; Robertson IH; Garavan H
    Neuropsychologia; 2011 Jun; 49(7):1641-50. PubMed ID: 21232548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association and linkage of allelic variants of the dopamine transporter gene in ADHD.
    Friedel S; Saar K; Sauer S; Dempfle A; Walitza S; Renner T; Romanos M; Freitag C; Seitz C; Palmason H; Scherag A; Windemuth-Kieselbach C; Schimmelmann BG; Wewetzer C; Meyer J; Warnke A; Lesch KP; Reinhardt R; Herpertz-Dahlmann B; Linder M; Hinney A; Remschmidt H; Schäfer H; Konrad K; Hübner N; Hebebrand J
    Mol Psychiatry; 2007 Oct; 12(10):923-33. PubMed ID: 17579611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Contribution of Maternal ADHD Symptomatology, Maternal DAT1, and Home Atmosphere to Child ADHD Symptomatology at 7 Years of Age.
    Auerbach JG; Zilberman-Hayun Y; Atzaba-Poria N; Berger A
    J Abnorm Child Psychol; 2017 Apr; 45(3):415-427. PubMed ID: 27873141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.
    Durston S; Fossella JA; Mulder MJ; Casey BJ; Ziermans TB; Vessaz MN; VAN Engeland H
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):61-67. PubMed ID: 18174826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the dopamine receptor D1 gene, DRD1, with inattention symptoms in families selected for reading problems.
    Luca P; Laurin N; Misener VL; Wigg KG; Anderson B; Cate-Carter T; Tannock R; Humphries T; Lovett MW; Barr CL
    Mol Psychiatry; 2007 Aug; 12(8):776-85. PubMed ID: 17310237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of dopamine transporter gene and observed parenting behaviors on attention-deficit/hyperactivity disorder: a structural equation modeling approach.
    Li JJ; Lee SS
    J Clin Child Adolesc Psychol; 2013; 42(2):174-86. PubMed ID: 23153115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine transporter (DAT1/SLC6A3) polymorphism and the association between being born small for gestational age and symptoms of ADHD.
    Waldie KE; Cornforth CM; Webb RE; Thompson JMD; Murphy R; Moreau D; Slykerman R; Morgan AR; Ferguson LR; Mitchell EA
    Behav Brain Res; 2017 Aug; 333():90-97. PubMed ID: 28666839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of dopamine transporter (DAT1) genotype and maltreatment for ADHD: a latent class analysis.
    Li JJ; Lee SS
    J Child Psychol Psychiatry; 2012 Sep; 53(9):997-1005. PubMed ID: 22646917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cingulate Cortical Thickness and Dopamine Transporter ( DAT1) Genotype in Children and Adolescents With ADHD.
    Fernández-Jaén A; Albert J; Fernández-Mayoralas DM; López-Martín S; Fernández-Perrone AL; Jimenez de la Peña M; Calleja-Pérez B; Recio Rodríguez M; López Arribas S
    J Atten Disord; 2018 May; 22(7):651-660. PubMed ID: 27160695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the dopamine transporter gene on neuroimaging findings in different attention deficit hyperactivity disorder presentations.
    Bacanlı A; Unsel-Bolat G; Suren S; Yazıcı KU; Callı C; Aygunes Jafari D; Kosova B; Rohde LA; Ercan ES
    Brain Imaging Behav; 2021 Apr; 15(2):1103-1114. PubMed ID: 33469789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls.
    Shook D; Brady C; Lee PS; Kenealy L; Murphy ER; Gaillard WD; VanMeter JW; Cook EH; Stein M; Vaidya CJ
    Am J Med Genet B Neuropsychiatr Genet; 2011 Jan; 156B(1):28-35. PubMed ID: 20957668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine transporter genotype predicts attentional asymmetry in healthy adults.
    Newman DP; O'Connell RG; Nathan PJ; Bellgrove MA
    Neuropsychologia; 2012 Oct; 50(12):2823-2829. PubMed ID: 22940645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.